PRME
Prime Medicine, Inc.
3.50$
+11.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | 0.05 | 0.00 | 0.05 | 0.00 | 0.03 | 0.03 | |
| 0.03 | 0.03 | 0.05 | 0.12 | 0.05 | 0.05 | 0.05 | |
| -0.03 | 0.02 | -0.05 | -0.12 | -0.05 | 0.03 | -0.02 | |
| 0.01 | 0.03 | 0.74 | 0.89 | 1.63 | 1.31 | 1.08 | |
| 0.04 | 0.03 | 0.15 | 0.31 | 0.48 | 0.42 | 0.35 | |
| 0.02 | 0.03 | 0.88 | 1.20 | 2.25 | 1.73 | 1.38 | |
| -0.02 | -0.01 | -0.88 | -1.20 | -2.25 | -1.71 | -1.40 | |
| – | 0.11 | 0.85 | 0.12 | – | – | – | |
| -0.03 | -0.02 | -1.73 | -1.26 | -2.18 | -1.65 | -1.35 | |
| 0.00 | 0.02 | -0.01 | -0.01 | 0.00 | – | – | |
| -0.03 | -0.04 | -1.73 | -1.25 | -2.18 | -1.65 | -1.35 | |
| -0.02 | -0.01 | -1.73 | -1.24 | -2.05 | -1.60 | -1.32 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.